Table 2:

Comparison of study end points between SAPT and DAPT^{^a}

	SAPT (n = 90)	DAPT (n = 132)	P Value
Complications
Thromboembolic (all)	6	12	.188
Thromboembolic (permanently disabling)	0	5	<.001^{^b}
Hemorrhagic	0	3	.003^{^b}
Intimal hyperplasia/asymptomatic parent artery occlusion	3 (2.9%) mild/3 (2.9%)	6 (4.0%) mild/2 (1.3%)	.768
Radiologic and clinical follow-up
Follow-up duration	18 (SD, 12.3) (3–60)	18 (SD, 12.6) (6–74)	.553
Complete occlusion (RROC I) at latest follow-up	82 (80.4%)	115 (78.2%)	.367
Good clinical outcome at latest clinical follow-up (mRS 0-1)	90 (100%)	116 (87.8%)	<.001^{^b}

↵a Data are mean (SD) (minimum-maximum) or absolute number of cases (relative frequency in percentages).
↵b Statistically significant.